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Abstract This study reports the establishment of three
major subtypes of human mesothelioma cells in tissue
culture, i.e. the epithelioid, sarcomatoid and biphasic
forms, and compares their phenotypic and biological
characteristics. Primary cells isolated from biopsies or
pleural exudates were subcultured for over 50 passages.
We evaluated immunoreactivity using various mesothelial
markers related to histological patterns of these cell lines.
For epithelioid cells, calretinin and cytokeratin were
found to be useful and easily interpretable markers as for
control mesothelial cells. The biphasic form was only
partially positive and the sarcomatoid type negative. Vi-
mentin was expressed by all cell lines. BerEP4, a specific
marker for adenocarcinoma, was negative. Interestingly,
while the macrophage marker CD14 was negative, im-
munoreactivity for a mature macrophage marker (CD68)
was expressed by all cell types, suggesting that this
marker might constitute an additional tool useful in the
differential diagnosis of mesothelioma. At the ultrastruc-
tural level, a cell surface rich in microvilli confirmed their
mesothelial origin. PCR analysis revealed that none of the
cell lines contained SV40 DNA. Karyotypic analyses
showed more complex abnormalities in the epithelioid
subtype than in the sarcomatoid form. These cell lines
may be useful in the study of cellular, molecular and
genetic aspects of the disease.
Keywords Malignant mesothelioma · Epithelioid ·
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Introduction
Malignant cells of mesothelial origin derived embry-
ologically from the mesoderm exhibit different histolog-
ical features and share characteristics of both epithelial
and mesenchymal cells (Mutsaers 2002; Whitaker et al.
1982). Cytoarchitectural patterns have been used to de-
scribe three different subtypes of malignant mesothelioma
(MM) depending on the predominant cell type present in
the tumour. These subtypes range from the purely epi-
thelioid form resembling adenomatous carcinomas, to the
sarcomatoid group. Often these two cell types are mixed,
thus forming the biphasic mesotheliomas which represent
the most common type of MM (Attanoos and Gibbs 1997;
Hoogsteden et al. 1997; Travis et al. 2003). Moreover,
histiocytic infiltrates characterised by the presence of
small cells in pleural effusions and biopsies, giving rise
to “small cell” or “lymphohistiocytoid” mesothelioma
(Attanoos and Gibbs 1997; Attanoos et al. 2001; Biele-
feldt-Ohmann et al. 1994), can be confused with these cell
populations in spite of the difference in size between the
two cell types. The ability to perform cell and molecular
biological analyses on the various MM subtypes is hin-
dered by the scarcity of appropriate cell lines. Indeed,
whereas the development of cell lines has been important
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for studying the biological properties of cancer, only few
mesothelioma cell lines have been established (Manning
et al. 1991; Orengo et al. 1999; Pass et al. 1995; Zeng et
al. 1994), as opposed to lung cancer where many estab-
lished cell lines are available. Most of these cell lines
could not be cultured beyond 20 passages.
Histological diagnosis of MM is rendered problematic
by the structural variability between different tumours and
the subtypes of mesotheliomas. There is no specific
marker for mesothelioma, and antibodies that recognise
molecules expressed by mesothelial cells and mesothe-
liomas were noted to have limited specificity or sensi-
tivity. Differences have been noted between epithelioid
and sarcomatoid subtypes of mesothelioma, as well as
between the sarcomatoid form of MM and adenocarci-
nomas. However, it is generally agreed that no one anti-
body shows absolute regularity or specificity in distin-
guishing the epithelioid from the sarcomatoid type
(Abutaily et al. 2002; Attanoos et al. 2001). Recently
calretinin, a 29-kDa calcium-binding protein that is ex-
pressed in a specific set of neurons (Winsky et al. 1989),
has been shown to be a potentially useful marker for
differentiating MM in histological preparations (Doglioni
et al. 1996; Gotzos et al. 1996; Tos and Doglioni 1998)
although results have sometimes been conflicting (Leers
et al. 1998; Simsir et al. 1999).
Characterisation of cell lines as being of mesothelial
origin and carrying a malignant phenotype is also based
on cytogenetic and karyotypic analysis (Kaplan and
Hukku 1998; Pass et al. 1995; Versnel et al. 1994). Be-
cause most MM are associated with asbestos exposure,
the long latency period between asbestos exposure and the
onset of MM results in a multistep tumorigenesis process.
Cytogenetic analysis reported from fresh patient samples,
short-term and long-term cultures or established cell lines
demonstrated complex karyotype abnormalities (Pass et
al. 1995). However, no specific chromosomal deletions,
translocations or inversions could give hints concerning
changes responsible for the carcinogenic transformation.
Furthermore, many investigators have suggested that
simian virus 40 (SV40) DNA sequences, possibly origi-
nating from contaminated poliovirus vaccines that were
administered in the USA and some European countries
between 1955 and 1963, might function as a cocarcinogen
involved in the development of the disease (Carbone et al.
1999, 2003; Mossman and Gruenert 2002). The onco-
genic potential of SV40 has been reported to depend on
the SV40 large T-antigen (Tag) (Bocchetta et al. 2000;
Rizzo et al. 2001). Moreover, the presence of Tag DNA
sequences in MM cells has been shown by several groups
using the polymerase chain reaction (PCR). However, the
causal relationship between SV40, SV40 Tag, MM and
asbestos remains uncertain (Galateau-Salle et al. 1998;
Pilatte et al. 2000; Simsir et al. 2001).
We have established cell lines belonging to three dif-
ferent subtypes of human mesothelioma, and character-
ised them with regard to morphology, antigenic markers,
ultrastructure, cytogenetic profile and the presence of
possible cocarcinogenic factor such as SV40 associated
with the onset of MM. Using some new antibodies in
addition to a standard panel we suggest that the cell
populations display stable, homogenous characteristics
within a given line. Such cell lines are expected to help
establish reliable markers useful in the characterisation of
various forms of MM.
Materials and methods
Reagents and antibodies
NCTC-109 medium, l-glutamine and trypsin-EDTA were pur-
chased from Gibco (Invitrogen Life Technologies, Basel, Switzer-
land) and fetal calf serum (FCS) from Inotech (Dottikon, Switzer-
land). Mouse monoclonal antibodies (mAb) to human cytokeratin
clones AE1/AE3, anti-swine vimentin mAb clone V9, anti-human
macrophage CD68 mAb clone KP1, anti-human monocyte CD14
mAb clone TUK4, irrelevant mouse IgG mAb used as isotype
control and mouse mAb to the adenocarcinoma glycoprotein marker
BerEP4 were all purchased from Dakopatts (Glostrup, Denmark).
Monoclonal antibody to cytokeratins 8, 18 and 19 clone 5D3 was
provided by BioGenex, CA, polyclonal rabbit anti-calretinin DC8
antibody by Zymed Laboratories, CA, and fluorescein isothiocy-
anate (FITC)-conjugated rabbit anti-mouse IgG, FITC dichloro-
triazinyl-aminofluorescein (DTAF)-conjugated goat anti-mouse
IgG + IgM and R-phycoerythrin (RPE)-conjugated goat anti-mouse
IgG by Jackson Immunoresearch, Milian Analytica (La Roche,
Switzerland). Primers for SV40 assay by PCR were obtained from
Invitrogen, and virus-positive control (SV40) was a gift from Dr.
Peter Beard (ISREC, Epalinges, Switzerland).
Cultures and isolation of clones for cell proliferation
Tumour specimens (surgical samples and fluids of pleural effusions
collected via a sterile evacuative thoracentesis system) were ob-
tained from patients with untreated MM after informed consent
through collaboration with clinicians and in full compliance with
ethical guidelines. Two samples were from the epithelioid form of
MM, two from the sarcomatoid and two from the mixed type. All
cultures were performed in NCTC-109 medium supplemented with
10% heat-inactivated FCS and 0.02 mg/ml l-glutamine and main-
tained at 37C in a humidified atmosphere of 5% CO2 and 95% air.
For pleural effusions, samples were centrifuged (400 g for
5 min) and the pellets washed and distributed in 75-cm2 flasks
(Falcon, Becton Dickinson; 2106 cells in 20 ml medium). Im-
portantly, the medium was changed every 3 days in order to remove
contaminating inflammatory cells, which were floating or spread
out on the tumour cells. After confluence, the cells were further
kept in the same medium for 2 weeks or more, to allow for death of
the remaining inflammatory cells. Cells were then treated by
trypsin-EDTA for 5 min at 37C. Pure populations of MM cells
were obtained after three to four passages. Control pleural effusions
from patients with benign inflammation were similarly processed in
order to obtain cultures of normal mesothelial cells. Monolayer
cultures of these normal cells could be maintained for three to six
passages.
Biopsy samples were cut into small pieces (approximately 1–
3 mm) and plated in large Petri dishes (10020 mm; Falcon)
containing 12 ml medium. They were cultivated for 2–4 weeks
without changing the medium, during which time colony formation
was observed. To prepare cell lines, colonies were isolated by
scraping all other cells in the dish with a rubber policeman, washed
and then detached with trypsin-EDTA; after washing, the cells were
plated and allowed to grow to confluence. Cultures from biopsy
samples were found to be more efficient in developing into ho-
mogeneous populations than cultures from pleural fluids. For all
cell lines, the NCTC medium was changed every 8 days and cells
were replated according to their growth rate. Antibiotics were used
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only in the first preparation of biopsies and the following cultures
were performed without antibiotics.
Immunoreactive assay and cell identification
To confirm their mesothelial origin, the cells were detached with
trypsin-EDTA, washed twice and centrifuged on microscope slides
in a Cystospin 2 centrifuge (Shandon, UK), fixed for 10 min in
absolute ethanol, air-dried and stored at 4C. For staining for
cytokeratins, calretinin and CD68, a second fixation was performed
with buffered formol solution (PBS/formol 4%) at room tempera-
ture (RT) for 15 min and the preparations were then rinsed with
running distilled water for 5 min at RT. Prior to staining with
antibodies, the smears were boiled for 10 min in 10 mM citrate
buffer solution pH 6.0, allowed to cool down in the same solution at
RT for 20 min and rinsed once in distilled water, in PBS and then in
PBS/BSA 0.5% for 15 min. They were then processed using a Dako
autostainer Universal staining system (Dako). The slides were in-
cubated with diluted primary antibodies, i.e. a pool of monoclonal
anti-cytokeratin AE1/AE3 (diluted 1:25 dilution in PBS/BSA
0.5%), and anti-cytokeratins 8, 18 and 19 antibodies (diluted
1:100), anti-calretinin (1:100) and anti-CD68 (1:200) antibodies for
1 h at RT. Without formol postfixation or boiling, preparations
were treated with anti-vimentin (1:20), anti-CD14 (1:20) or anti-
BerEP4 antibodies (1:100) in PBS/BSA for 1 h at RT and then
washed twice in PBS/BSA. All samples were incubated with biotin-
labelled anti-mouse or anti-rabbit Ig secondary antibody (1:250 in
PBS/BSA) for 30 min at RT followed by washing in TRIS-buffered
saline (TBS). Final immunostaining was obtained using streptavi-
din-alkaline phosphatase and the appropriate chromogen for 30 min
at RT. All slides were counterstained for 10 min with fast red,
rinsed in water, covered with a coverslip using Aquatex (Merck,
Glattbrugg, Switzerland) and visualised with a Zeiss microscope
(Axiophot, Oberkochen, West Germany). For controls, isotype-
matched antibodies (Dakopatts) were used or the primary anti-
bodies were omitted. The presence of BerEP4 and CD68 was also
tested for on frozen samples of adenocarcinomas as controls in
order to confirm that CD68 mAb reacts as a selective marker for
cells of mesothelial origin, but not for adenocarcinoma cells. Fur-
thermore, representative biopsy samples from tumour correspond-
ing to each cell line were routinely processed as formalin-fixed
paraffin-embedded material. Sections were cut for morphological
examination using the avidin-biotin-peroxidase complex (ABC)
method and examined using a Zeiss Axiophot microscope.
Flow cytometry analysis
Phenotypic analysis was confirmed by exploring cell expression of
calretinin, keratin, vimentin, CD68, CD14 and BerEP4 by fluo-
rescence-activated cell sorting (FACS). Cells detached with tryp-
sin-EDTA were centrifuged in NCTC medium + 10% FCS, washed
twice in PBS and fixed in a solution of 2% paraformaldehyde in
0.1 mM phosphate buffer (pH 7.4) at 4C for 45 min. After three
washes in PBS, the last one in PBS/BSA 0.1%, they were incubated
with antibodies. Each staining step lasted 30 min at 4C and was
followed by two washes in PBS/BSA. A double staining method to
detect the CD68 antigen in combination with keratin or calretinin
was also used. The preparations were then treated with a secondary
DTAF-conjugated goat or rabbit anti-mouse IgG, or RPE-conju-
gated goat anti-mouse IgG, depending on the experiment. FACS
data acquisition and analysis were performed using CELL-Quest
software (Becton Dickinson).
Transmission electron microscopy (TEM)
Detached cells were washed and centrifuged at 400 g, and the
pellets were prefixed for 10 min at 4C in 0.2% glutaraldehyde in
cacodylate buffer and then recentrifuged, refixed for 1 h in 2%
glutaraldehyde in cacodylate buffer at 4C, washed in the same
buffer and postfixed in 1% osmium tetroxide at 4C for 1 h.
Samples were dehydrated in a graded alcohol series, then propylene
oxide and embedded in Epon. Ultrathin sections were examined in
a Philips 400 electron microscope.
Chromosomal analysis
Cytogenetics and karyotyping were performed using cells in tissue
culture following in situ treatment with colcemid for 3 h at a final
concentration of 0.1 mg/ml. The cells were then treated with a
hypotonic solution and fixed in a methanol-acetic acid solution.
Trypsin-Giemsa staining banding was effected for assignment of all
chromosomes in the karyotypes (Seabright 1971). Chromosome
counts were done on well-spread metaphases.
PCR analysis
The possible presence of SV40 infection of the cells growing in
culture from biopsies or pleural effusions was determined by PCR
using as primers SV3.for 50-TGA GGC TAC TGC TGA CTC TCA
ACA-30 and the reverse, SV.rev 50-GCA TGA CTC AAA AAA
CTT AGC AAT TCT G-30, which amplify a 105-bp fragment of
Tag. The reaction mixture had a final concentration of 100 ng
genomic DNA, 50 mM of each dNTP (Sigma), 0.2 mM of each
primer, 0.5 U of Taq DNA polymerase (Sigma) and 1.5 mM MgCl2
contained in the PCR buffer (Sigma) to a final volume of 25 ml. The
mixture was assembled for 2 min at 95C followed by 35 cycles of
10 s at 94C, 30 s at 62C, 40 s at 72C and a final extension of
5 min at 72C. The amplification products were resolved in an
ethidium bromide-stained 5% acrylamide gel. We analysed the
three tumour cell lines and included positive and negative controls.
Western blot analysis
Cells were harvested with 0.2% EDTA and solubilised in a lysis
buffer supplemented with a protease inhibitor cocktail and PMSF
(Complete; Roche, Basel, Switzerland). Lysates were clarified by
centrifugation at 4C and an equivalent amount of proteins from
each sample was used to analyse the profile of keratins and CD68
expression. Lysate samples were mixed with an equal volume of
SDS buffer and boiled at 95C for 5 min. Samples were then
subjected to SDS-polyacrylamide gel electrophoresis using a de-
naturing 6–20% gradient. Running and transfer conditions were as
recommended by the manufacturer (Amersham Biosciences Basel,
Switzerland). Proteins were transferred to nitrocellulose, blocked
for 1 h in TBS containing 0.1% v/v Tween 20 and 5% non-fat dry
milk. The membranes were incubated for 18 h at 4C with primary
antibodies, goat anti-actin (C-11) SC-1615 (Santa Cruz Biotech-
nology, CA) 1:250, mouse anti-CD68 mAb (1:200) and a pool of
anti-cytokeratin AE1/AE3 (4 ml) and anti-cytokeratins 8, 18, and 19
mAbs (2 ml) diluted 1:400. Antibody-reactive bands on the blots
were visualised by incubation with anti-mouse and anti-goat
horseradish peroxidase-conjugated mAbs diluted 2,500-fold for 2 h
at RT. The chemiluminescent signal was captured using ECL de-
tection reagents according to the manufacturer’s instructions
(Western Blotting kit; Amersham) and exposure on Kodak BioMax
Light film (Kodak, Switzerland). Purified macrophages, which
served as positive controls, were obtained from leukapheresis
samples after Ficoll Hypaque density gradient and 5 days adhesion
culture on collagen-coated plastic Petri dishes at 37C in 5% CO2
atmosphere in the presence of GM-CSF 200 U/ml in DMEM and
10% of FCS. Negative control, human normal fibroblast cell line is
a generous gift of Dr. J.M. Dayer, Cantonal Hospital of Geneva,
Switzerland.
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Results
Characterisation of primary tumour
To determine whether the contaminant cells can be totally
eradicated in tissue culture, biopsies were cultured and
monitored for cell proliferation. A typical mixed-type
MM culture developing from a tissue explant (Fig. 1A)
shows a heterogeneous population with multiple histio-
cytic cells. A more homogeneous cell population devel-
ops from a sarcomatoid-type MM biopsy (Fig. 1B). This
population was separated from the biopsy after a 3-week
culture and shows colony formation 4 weeks after re-
plating (Fig. 1C). Cells were then detached from the dish
as described in Materials and methods and replated in a
flask for proliferation, giving rise to a representative
sarcomatoid variant (Fig. 1D).
Three cell lines identified as JL1, DM3 and PJ2, of the
epithelioid, sarcomatoid and biphasic forms, respectively,
were successfully established from three out of six biopsy
specimens (JL1 and DM3) or pleural effusions (PJ2) from
patients. The three cell lines exhibited marked differences
in morphology. We considered as “epithelial” polygonal
cells those whose phenotype was nearest to that of me-
sothelial control cells, with centrally placed large nuclei;
the sarcomatoid-type cells consisted of spindle-shaped
cells which appeared triangular with long thick processes,
and indistinct oval nuclei; and the biphasic pattern was
composed of both elements. Three others cell lines pro-
gressed in tissue culture. At the time of writing this paper,
these cells have been maintained for over 40 (PJ2) and 52
(JL1, DM3) passages and could be regrown 2 years after
cryopreservation at different culture stages in vitro with
maintenance of their original morphology. Growth as
multilayers is a feature of all three cells lines. Even for the
PJ2 cell line, the mixed phenotype was still apparent after
30 passages. All cell lines grew as adherent layers and no
floating cells were observed at confluence in the culture
media. Sometimes dead cells in aged, multilayered cul-
tures of confluent epithelioid or biphasic forms could be
observed. The time for development of a line endowed
with stable characteristics was approximately 3–8 months.
The morphological differences between epithelioid and
sarcomatoid mesothelioma forms is illustrated by the JL1
cell line (Fig. 2A) and DM3 cell line (Fig. 2B) which
present the cells 41 and 22 passages after explantation,
respectively. After 4 weeks of culture, normal control
mesothelial cells become confluent (Fig. 2C). A typical
biphasic form originating from a pleural effusion (4 weeks
of culture) is contaminated with a noticeable number of
histiocytes (Fig. 2D), which is clearly different from the
pure epithelioid or sarcomatoid forms of MM. This culture
provided the PJ2 line; no contaminating histiocytes could
be detected beyond the sixth passage (not shown). Inter-
estingly, a strong correlation was observed between the
presence of histiocytic cells and poor proliferation of tu-
mour cells in the same culture. As a consequence, it was
found to be very important to carefully remove these
Fig. 1 A Phase-contrast micrographs of culture originating from a
mixed-type malignant mesothelioma (MM) biopsy (b; dark, lower
part of the picture), which shows both epithelioid (epi) and sarco-
matoid (sar) cell types migrating out of the explant. Histiocytic
cells (his) can also be observed. Inset: scale identical to main fig-
ure. B Biopsy (b) of a sarcomatoid mesothelioma (dark spot at the
right half of the picture) with cells migrating out of the explant.
This biopsy was cultured for 3 weeks and then treated with trypsin-
EDTA; the detached cells were plated and maintained for 4 weeks
(C). D is a representative sarcomatoid type MM culture. Scale bar
10 mm
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histiocytic cells to obtain a permanent culture of the tu-
mour cells.
Ultrastructural analysis
By TEM, the majority of cells from epithelioid-type MM
cultures were round, and exhibited typical long, thin,
surface microvilli or lamellar projections (Fig. 3) similar
to their parental normal mesothelial cells (not shown).
Cytoplasmic vesicles and vacuoles were abundant, and
well-developed structures such as rough endoplasmic re-
ticulum, mitochondria, lysosomes, intermediate filaments
and glycogen granules were evident in the three cell
types, which also contained large nuclei with nucleoli.
Immunophenotypic analysis of MM cell lines
Immunocytochemical studies were performed on the
subtypes of MM to evaluate the cell type-specific ex-
pression of various mesothelioma markers (Fig. 4). By
immunocytochemistry, calretinin and keratin were ex-
clusively expressed by the entire epithelioid cell popula-
tion (Fig. 4A, B). They are found to be useful and easily
interpretable markers with >98% positive cells as also
observed for normal mesothelial cells (not shown). These
markers are only partially positive by the mixed form
(30–50% cells) which also contained some epithelioid-
positive cells (Fig. 4C, D). No immunoreactivity was
observed for the pure sarcomatoid form (not shown).
Furthermore, the epithelioid- and sarcomatoid-type MM
cells, as well as the mixed type and control normal me-
sothelial cells, were all positive for both vimentin (>99%)
Fig. 2A–D Phase-contrast mi-
crographs of MM cells in tissue
culture. A JL1 epithelioid-type
mesothelioma cells (pas-
sage 41); the cells grow in
multilayers. B Sarcomatoid type
MM cells (DM3 line, pas-
sage 22). Note the typical
elongated cells growing as
multilayers. C Control, normal
mesothelial cells. D Mixed-
form MM culture (PJ2, 4-week
cultures) containing both round,
epithelioid cells (long arrow)
and elongated, sarcomatoid cell
types. Many histiocytes (ar-
rowheads) are also present.
Scale bar 20 mm
Fig. 3 Electron micrograph of a typical epithelioid MM cell ex-
hibiting slender, long surface microvilli (Mv), with abundant mi-
tochondria (Mit), lysosomal structures (Lys) and intermediate fila-
ments (IF). Scale bar 2 mm
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Fig. 4A–J Immunocytochemi-
cal staining of MM cells in
culture. A Epithelioid (JL1)
cells are positive for calretinin
with diffuse cytoplasmic stain-
ing pattern. B JL1 cells showing
intense staining for keratin. C,
D Cells of the mixed form PJ2
line: only the large, epithelioid
cells are positive for calretinin
(C) and keratin (D). E Epithe-
lioid-type (JL1) and F sarco-
matoid-type (DM3) cells show
staining for vimentin and CD68,
respectively. G, H Cells of the
mixed type are negative for
CD14 (G), whereas control pe-
ripheral blood leukocytes are
positive for this marker (H).
I Sarcomatoid cells are negative
for BerEP4. J IgG control anti-
bodies. Scale bar 10 mm for
A–G, I–J; 5 mm for H
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and CD68 (a marker for macrophages) (>97%); epitheli-
oid cells were stained for vimentin (Fig. 4E) and the
sarcomatoid cells for CD68 (Fig. 4F).
Anti-CD68 antibody appeared to stain intracytoplas-
mic granules. Whereas this marker was also positive on
frozen material from MM biopsies (not shown), it was
negative for adenocarcinoma cells (not shown). CD14,
another macrophage marker, was negative for all cell
lines (Fig. 4G), and was significantly expressed by
monocytes from the peripheral blood (Fig. 4H). The
absence of detectable staining for MM cell lines using
BerEP4, a marker for adenocarcinoma (Fig. 4I), supports
the difference between the two cell types. Normal me-
sothelial cells from the pleural cavity of patients with
benign inflammation were found to be positive for the
same markers as they were positive for MM (not shown)
thus confirming the mesothelial origin of the tumour cells.
Comparative studies by immunohistochemical staining of
representative tissue samples from MM biopsies revealed
the same results, indicating that the cultured cells main-
tained the immunohistochemical characteristics of the
parental tumour cells (not shown).
In addition, analysis of individual cells by flow cy-
tometry using a double-staining immunofluorescence
procedure was also performed (Fig. 5). A large percentage
(see Fig. 5A) of the JL1 tumour cells expressed both
calretinin (FITC) and CD68 (RPE) (Fig. 5A a, b). A
double-colour immunofluorescence staining showed co-
expression of CD68 and calretinin (Fig. 5A c). Staining
for CD14 was negative confirming a cell population dif-
ferent from macrophages (Fig. 5A d). The same experi-
ment (see Fig. 5B) was performed using the PJ2 cell line
prior to elimination of histiocytes. The line was positive
for CD68 and partially so for calretinin (Fig. 5B f, g). This
was confirmed with partial coexpression of CD68 and
calretinin (Fig. 5B h). CD14 expression was detected in a
population, most likely representing the contaminating
histiocytes (Fig. 5B i), that was clearly distinct from the
rest of the cells, which were essentially negative for this
marker. The same histiocytic population was negative for
calretinin, but also positive for CD68 (Fig. 5B h).
Using these antibodies, we also evaluated the expres-
sion of keratins and CD68 in cell lines by western blot
analysis. The lysate obtained from Triton X-100-treated
cells (Fig. 6A) gave results that support the immunocy-
tochemistry analysis for keratins with a strong positive
staining for normal mesothelial cells and epithelioid form
(JL1 cell line) (lanes 1 and 2, respectively), against a
partial staining of the mixed form PJ2 cell line (lane 3).
Cells from the sarcomatoid form (lane 4), macrophages
(lane 5) and fibroblasts (lane 6) are negative for this
protein.
In Fig. 6B, anti-CD68 antibodies stained a band with a
molecular weight of 110 kDa in NP40 lysates of the PJ2
cell line and macrophages (lanes 3 and 5, respectively).
Fibroblastic cells were not stained by anti-CD68 (lane 6).
Except for macrophages (lane 7), no staining of material
at this position was seen with Triton X-100 lysis treated
cells (Fig. 6B lanes 1, 2, 4). Actin was positive in all
conditions (Fig. 6A, B).
Karyotypic examination and PCR results
Cytogenetic analysis revealed abnormal karyotypes with
both numeric and structural chromosomal abnormalities.
The most frequent structural changes were fragment
deletions and/or translocations, trisomies and mono-
somies, particularly in the epithelioid form which presents
more restructurings and chromosomal alterations with
many amplifications or deletions (Fig. 7A). Many karyo-
types from the sarcomatoid form are normal or close to
those of normal cells showing few chromosomal alter-
ations (Fig. 7B). Unassignable chromosomes, particularly
in the epithelioid form, will be those that are neither
normal nor consistently present from one karyotype to
another.
By PCR analysis, no SV40-positive amplification was
detected in any of the three cell lines of MM studied. In
contrast the SV40-positive control was always detected
(not shown).
Fig. 5 A Flow cytometric analysis of antigen expression by cells of
the JL1 line. a Calretinin (Calr), b CD68, c double staining
showing a coexpression of CD68 and calretinin, d CD14, e IgG
control. B Experiment with a cell line contaminated with histio-
cytes. f 84% of 90% gated cells stain for CD68. Calretinin (g) is
positive for 43%; h Double staining where 47% of the cells stain for
both calretinin and CD68, whereas a discrete population (presum-
ably histiocytic and sarcomatoid type) is positive for CD68 but not
for calretinin (arrow). i 38% of cells are positive for CD14
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Discussion
Establishing stable and permanent primary cell lines
represents an essential tool to study MM at the cellular
and molecular level and to test therapeutic approaches.
Up to now, no human mesothelioma cell lines have been
successfully established. Using cells from tumour biop-
sies and fluids from pleural effusions of patients with the
disease, homogenous cultures of different MM subtypes
were obtained. These lines have been used to analyse
differences in marker expression between the epithelioid
and sarcomatoid forms, which may be of use in the further
histological characterisation of primary tumour.
Markers capable of identifying MM unambiguously are
scarce. MM are considered negative for antibodies to
carcino-embryonic antigen (CEA), CD15, the epithelial
glycoprotein Bg8 and the tumour glycoproteins BerEP4
and MOC-31, while these markers are usually positive for
adenocarcinomas (Oates and Edwards 2000; Riera et al.
1997; Wirth et al. 1991). The antibodies most commonly
used for identification of MM cells are anti-calretinin,
which reacts with epithelioid-type mesotheliomas (At-
tanoos et al. 2001; Doglioni et al. 1996; Gotzos et al. 1996;
Tos and Doglioni 1998), and anti-cytokeratins (Clover et
al. 1997; Whitaker 2000); both antibodies have been found
useful in separating epithelioid mesothelioma (positive
staining) (Clover et al. 1997; Doglioni et al. 1996; Gotzos
et al. 1996; Whitaker 2000) from adenocarcinoma (nega-
tive staining) (Ordonez 1998a, b). Other positive markers
for mesotheliomas have been described recently, including
HBME-1 (Ordonez 1997), mesothelin (Chang and Pastan
1996), N-cadherin (Han et al. 1997), thrombomodulin
(Collins et al. 1992; Ordonez 1997) and Wilms’ tumour
gene product (Amin et al. 1995). Although most attention
has been given in recent years to the immunostaining
separation of epithelioid MM from metastatic adenocar-
cinoma, antibodies used for that purpose are generally not
helpful in the differential diagnosis of non-epithelioid MM
variants (Wick and Mills 2000). Distinction in calretinin
and cytokeratin expression have been recognised as po-
tential means of differentiating between the epithelioid
form, positive, and the sarcomatoid type, negative for
these antibodies (Clover et al. 1997; Gotzos et al. 1996). In
the present study, positivity of the JL1 cell line for cal-
retinin and cytokeratins excludes the presence of a sub-
pleural carcinoma growing in a pseudomesotheliomatous
pattern.
The morphology of the JL1 and DM3 cell populations
was homogeneous for the epithelioid and the sarcomatoid
form, respectively. The use of well-differentiated cell
types produced impressive discriminatory expression of
the markers recognised by anti-calretinin and anti-cyto-
keratin antibodies. Interestingly, western blotting results
which are consistent with immunocytochemistry findings
indicated that only epithelioid cells express these proteins.
Some reports have cast doubt on the value of calretinin as
a diagnostic marker probably because of the use of less
well differentiated tumour or mixed cell populations
Fig. 6 A Cells were lysed in a medium containing 1% Triton X-
100 and a mixture of protease inhibitors. The proteins were then
treated as indicated in Materials and methods. Western blot anal-
yses were performed with the antibodies/antisera against the indi-
cated keratins in human mesothelial cells, cell lines and controls.
Lanes 1–6 represent marker proteins under reducing conditions in
extracts of normal mesothelial cells (lane 1), epithelioid cells (JL1,
lane 2) and mixed cells (PJ2, lane 3). Keratins were not expressed
by the sarcomatoid type (DM3, lane 4), macrophages (5 day cul-
ture, lane 5) and normal fibroblasts (lane 6) as negative control. All
samples were loaded with 25 mg of proteins. B Western blot
analysis of CD68 expression. Samples in lanes 1, 2, 4 and 7 are
from extracts obtained using Triton X-100; cells from lanes 3, 5
and 6 were homogenised in 50 mM HEPES, pH 7.5, containing 1%
Nonidet P40, 0.25% sodium deoxycholate, 5 mM EDTA, 150 mM
NaCl, 50 mM NaF, 1 mM sodium orthonovanadate and protease
inhibitors. Lane 1 Normal mesothelial cells, lane 2 Jl1 cells, lane 3
PJ2 cells, lane 4 DM3 cells, lanes 5 and 7 normal macrophages,
lane 6 fibroblasts. All samples were performed under reducing
conditions. Lanes 3, 5 and 7 show 110-kDa bands detected by the
anti-CD68 KP1 antibody in extracts of PJ2 cell line and purified
macrophages after 5 days of culture. In each condition 20 mg of
proteins were used
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(King and Hasleton 2001). The detection of calretinin-
and keratin-positive epithelioid cells does not serve to
identify the sarcomatoid type of MM (Clover et al. 1997;
Doglioni et al. 1996; Gotzos et al. 1996). However, these
markers may nevertheless be useful because the biphasic
form represents the most current group of mesothelioma-
containing areas with both sarcomatous and epithelial
features.
While the cell lines were negative for CD14 immu-
noreactivity, staining for CD68 was strongly positive for
all cell lines as well as for control normal mesothelial
cells by immunocytochemistry and flow cytometry.
Constitutive expression of the CD68 antigen was also
demonstrated by western blot analysis of cells extracted
by NP40 (but not with Triton X-100). Conversely, fi-
broblastic cells were negative. This finding confirmed
that KP1 is a valuable addition to a panel of mAbs for
Fig. 7 A Representative karyo-
typic analysis of the epithelioid
JL1 cell line showing many
structural anomalies, mono-
somies and trisomies. Un-
assignable chromosomes (mar),
grouped between chromosome
numbers 3 and 4, represent non-
identifiable chromosomes with
structural anomalies not con-
sistently present from one
karyotype to another. B Repre-
sentative karyotype from the
DM3 sarcomatoid line with far
fewer chromosomal abnormali-
ties
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phenotyping mesothelioma cells. Few authors have de-
scribed immunoreactivity for CD68 in mesothelioma
cells. Positivity for this marker was attributed to the
proliferation of histiocytic cells, based on morphological
features and immunohistochemical stains (Chan et al.
1997; Wu et al. 2000). However, the immunoreactivity of
CD14 to help determine the true histiocytic identity of
these cells was not established. CD68 is a 110-kDa in-
tracellular glycoprotein primarily associated with cyto-
plasmic granules and to a lesser extent with the membrane
of macrophages, monocytes and some other granular
leucocytes (Holness and Simmons 1993). Designated as
macrophage marker, anti-CD68 antibodies also demon-
strated a variety of staining patterns in lymphocytes and
some non-haematopoietic cells, which are related to the
presence of lysosomal glycoproteins (Hameed et al. 1994;
Pulford et al. 1990). The exact function of CD68 remains
undefined. However, based on the structural homology
with mononuclear cells, the expression of this molecule
in MM could be associated with some properties of
phagocytic cells, such as pinocytosis and phagocytosis.
As previously described by others for epithelial cells
(Doussis et al. 1993), our observation confirms that anti-
CD68 antibodies, especially the KP1 clone used in our
experiment, are specific mainly for organelles and not for
a cell type, thus, the staining of mesothelial cells con-
taining multiple granules and lysosomes is possible. Our
data are consistent with other reports showing that anti-
CD68 also reacts with granular cell neoplasms (Doussis et
al. 1993; Tsang and Chan 1992) and malignant melano-
mas (Facchetti et al. 1991). Consequently, the constitutive
expression of CD68 by MM cells extends their im-
munophenotypic similarities with mesenchymally derived
mononuclear phagocytes and provides an additional an-
tigenic marker for the diagnosis of mesothelioma.
Ultrastructural observations provided convincing evi-
dence that the epithelioid form of tumour cells repre-
sented the fully differentiated mesothelial cells, except
that sarcomatoid cells tend to lose the specialised features
of epithelial cells when undergoing spindle cell transfor-
mation (Hammar and Bolen 1985). Moreover, the JL1 cell
line showed the typical characteristics of mesothelial
cells, presenting microvilli with a length to diameter ratio
>15 and intracytoplasmic vesicles with basal lamina as
reported elsewhere (Ordonez and Mackay 1998; Oury et
al. 1998).
Recent studies have suggested that SV40 may be a
factor in the development of MM, although the patho-
genic mechanism remains unclear (Carbone et al. 1999,
2003; Testa et al. 1998). However, other laboratories have
reported different results and concluded that SV40 is not a
contributing factor in the pathobiology of MM, or argued
that the SV40 DNA detection is probably a PCR con-
tamination artefact (Galateau-Salle et al. 1998; Pilatte et
al. 2000; Simsir et al. 2001). The effect of infection of
human mesothelial cells by SV40 is unknown, because
few mesothelial cell lines have been studied. Hence the
role of SV40 in the pathogenesis of MM, as suggested by
the susceptibility of human mesothelial cells to SV40
virus infection, remains an open question (Galateau-Salle
et al. 1998; Pilatte et al. 2000; Rizzo et al. 2001; Simsir et
al. 2001). In any case, the presence of SV40 DNA se-
quences was not detected in any of the three cell lines
studied.
Cytogenetic analysis, performed on epithelioid and
sarcomatoid cell lines between the 8th and 30th passages,
revealed complex patterns of chromosomal abnormalities.
Interestingly, karyotypes of the epithelioid cell lines re-
vealed more chromosomal alterations than the sarcoma-
toid form. Translocations, deletions and inversions have
been reported in the literature (Balsara et al. 1999;
Hagemeijer et al. 1990; Hansteen et al. 1993). Further
studies will be required to determine whether malignant
transformation in this type of cancer is associated with
identifiable chromosomal abnormalities.
To summarise, this study reports methodological
conditions allowing purification and maintenance of MM
cell lines in tissue cultures. These cell lines display the
specific morphological characteristics of the epithelioid,
sarcomatoid and biphasic forms, and show distinct ex-
pression patterns for specific markers as well as exhibit-
ing various karyotypic abnormalities. These findings
provide a structural basis for a better understanding of the
cellular, molecular and genetic aspects of the disease.
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